Geroscience in the age of COVID-19

Nir Barzilai, James C. Appleby, Steven N. Austad, Ana Maria Cuervo, Matt Kaeberlein, Christian Gonzalez-Billault, Stephanie Lederman, Ilia Stambler, Felipe Sierra

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

The data on COVID-19 is clear on at least one point: Older adults are most vulnerable to hospitalization, disability and death following infection with the novel coronavirus. Therefore, therapeutically addressing degenerative aging processes as the main risk factors appears promising for tackling the present crisis and is expected to be relevant when tackling future infections, epidemics and pandemics. Therefore, utilizing a geroscience approach, targeting aging processes to prevent multimorbidity, via initiating broad clinical trials of potential geroprotective therapies, is recommended.

Original languageEnglish (US)
Pages (from-to)725-729
Number of pages5
JournalAging and Disease
Volume11
Issue number4
DOIs
StatePublished - 2020

Keywords

  • Aging biomarkers
  • COVID-19
  • Geroprotectors
  • Geroscience
  • Immunosenescence

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Geriatrics and Gerontology
  • Clinical Neurology
  • Cell Biology

Fingerprint Dive into the research topics of 'Geroscience in the age of COVID-19'. Together they form a unique fingerprint.

Cite this